PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 

ALPCO

Press Releases

Click on the press release below to view it in its entirety

Receive press releases from ALPCO: By Email RSS Feeds:
ALPCO awards its January 2019 Diabetes Research Travel Grant to Lisa Volpatti at Massachusetts Institute of Technology. - February 05, 2019
ALPCO announces launch of its new highly specific FDA Class I Exempt STELLUX® Chemi Glucagon ELISA. - October 23, 2018
ALPCO announces the first recipient of its new young investigators award, the Diabetes Research Travel Grant. - October 17, 2018
ALPCO announces that its quality management system recently received the distinguished ISO 13485:2016 certification from Intertek to ensure the quality, safety and efficacy of its products in the clinical diagnostics field. - October 09, 2018
ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo. - July 25, 2018
ALPCO and InSphero announce partnership to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. - July 24, 2018
ALPCO, a leading producer of research and clinical immunoassays, recently announced the launch of its STELLUX® Chemi Active GLP-1 (7-36) amide ELISA. The chemiluminescence ELISA features increased sensitivity to accurately quantify active GLP-1 (7-36) amide levels as low as 1.5 pg/mL with a 25 µL... - July 17, 2018
ALPCO will promote its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at the American Diabetes Association’s 78th Scientific Sessions June 22-26, 2018 in Orlando, FL. - June 19, 2018
ALPCO announced it will feature a variety of products supported by its assay qualification program at the AACC’s 69th Annual Scientific Meeting and Clinical Lab Expo in San Diego August 1-3, 2017. Among these products is the Easy Stool Extraction Device and a Therapeutic Drug Monitoring ELISA portfolio. - July 25, 2017
The STELLUX® Chemiluminescent Plate Reader offers a simple plug-and-play setup, and is the ideal size for any lab. ALPCO’s Field Applications Scientist will be on-site at the ADA’s 77th Scientific Sessions offering live demonstrations of the new STELLUX® Chemiluminescent Plate Reader. - June 07, 2017
ALPCO and InSphero will team up at the ADA’s 77th Scientific Sessions to enhance the study of islet function, regeneration, and preservation by providing researchers with methods to perform 3D islet microtissue culture, as well as assays for measuring glucagon secretion and glucose-regulated insulin assays. - June 06, 2017
ALPCO will launch new gastrointestinal and inflammatory bowel disease (IBD) assays at Digestive Disease Week® May 7-9, 2017 in Chicago, IL. Included in this launch are two Zonulin ELISAs for the study of gut permeability and celiac disease, as well as therapeutic drug monitoring assays for IBD. - May 02, 2017
ALPCO is now offering a line of research assays for the investigation of common bacterial and parasitic gastrointestinal (GI) pathogens including Giardia lamblia, Cryptosporidium spp., Blastocystis hominis, Entamoeba histolytica/dispar, and Clostridium difficile. These assays can be used to research... - November 15, 2016
ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016
ALPCO has launched its new STELLUX® Chemiluminescent Plate Reader, an economical and versatile system for any size lab. - September 20, 2016
The new STELLUX® Chemi Active GLP-1 ELISA from ALPCO features superior sensitivity and requires only 10 µL of sample. - September 13, 2016
ALPCO has released new and improved versions of their Total Adiponectin and HMW & Total Adiponectin ELISAs which allow researchers to confidently measure adiponectin for the study of high molecular weight (HMW) to total ratios. - August 17, 2016
ALPCO now has a new broad range Periostin ELISA capable of measuring elevated levels of periostin consistent with current research. - June 07, 2016
ALPCO recently announced the release of its Bioactive Leptin ELISA, offering diabetes and obesity researchers a new tool to differentiate between leptin resistance and non-functional leptin. The assay allows for the measurement of leptin in human serum through the process of binding leptin to leptin... - April 26, 2016
ALPCO announced the launch of its new STELLUX® Chemi Human IL-6 ELISA - the first cytokine assay in the STELLUX® Chemiluminescence product line. - April 06, 2016
ALPCO recently announced the release of its new NT-proBNP (1-76) ELISA, offering researchers investigating cardiovascular disease, kidney disease, and diabetes with a flexible, user friendly and cost effective tool. The assay is highly characterized to measure changes in levels of NT-proBNP, and can... - February 23, 2016
ALPCO has released its new InhibiScreen Basophil Activation Test (BAT) which was developed and validated specifically for the evaluation of kinase inhibitors during early drug development. - February 16, 2016
ALPCO recently launched a new panel of 13 stool-based gastroenterology assays that are all compatible with one single extraction step, allowing labs to improve sample processing time by up to 86%. - January 26, 2016
ALPCO has launched its new STELLUX® Chemiluminescent Total Adiponectin and HMW Adiponectin ELISAs. - August 25, 2015
Starting on July 1, Cisbio US, Inc. will have exclusive access to ALPCO's colorimetric and STELLUX® Chemiluminescent Diabetes and Obesity products. - July 01, 2015
ALPCO recently launched a brand new website. The site was designed and developed to offer their customers a new and improved experience when searching for and buying immunoassay products. The website’s key features allow for more intuitive browsing and navigation on any device. ALPCO’s online... - June 16, 2015
ALPCO adds to their STELLUX® Chemiluminescent line of assays with the launch of the new Human C-peptide ELISA. - December 10, 2014
A new menu of pancreatic cell antibodies for the identification and isolation of major human pancreatic cell types is now available from ALPCO. - August 07, 2014
In response to recent reports that pancreatic cancer deaths are on the rise globally, ALPCO has released a line of pancreatic antibodies to provide the research community with reliable tools that can be used to better analyze and understand pancreatic cancer. - July 29, 2014
ALPCO has expanded EuroFlow™ product offering with addition of the Plasma Cell Screening Tube from Cytognos S.L. - April 03, 2014
ALPCO has launched their new STELLUX™ Chemi Human Intact Proinsulin ELISA, the latest addition to their chemiluminescent product line. - February 18, 2014
ALPCO expands test portfolio for clinical and hospital laboratory customers with the release of a FDA 510(k) cleared 25-OH Vitamin D Total ELISA. - January 22, 2014
A new Human Total Proinsulin ELISA is launched in ALPCO's STELLUX™ Chemiluminescent line of assays. - November 19, 2013
Earlier this year, ALPCO began offering flow cytometry reagents and data analysis software. As promised, the company has recently added high quality and affordable mouse reagents to their growing flow cytometry portfolio. Among the 600 new mouse reagents are antibodies for CD3, CD4, CD8 and CD45. “We're... - October 29, 2013
ALPCO releases second chemiluminescent assay in STELLUX™ product line. - October 24, 2013
New distribution agreement allows ALPCO to distribute NAG assays from PPR Diagnostics. - June 13, 2013
ALPCO launches the second species-specific kit in a line of Osteopontin ELISAs. - May 31, 2013
The partnering companies will feature BÜHLMANN's Fecal Calprotectin ELISA that is pending FDA clearance for IVD use in the United States. - May 16, 2013
ALPCO now offering a line of RIA products from Cisbio in the United States. - May 07, 2013
ALPCO launches the first assay in a new line of species-specific Osteopontin ELISAs. - May 01, 2013
Starting April 30, 2013 ALPCO will begin offering flow cytometry solutions from Cytognos S.L. - April 30, 2013
ALPCO announces the launch of their STELLUX Rodent Insulin ELISA, the first ELISA launched in their new STELLUX Chemiluminescent assay product line. - April 26, 2013
After over twenty years of providing immunoassay kits worldwide, ALPCO has added flow cyometry reagents to their product offering. - March 25, 2013
ALPCO will distribute Infectious Disease assays from GBC in North America. - December 18, 2012
ALPCO presented with plaque of recognition for their contribution to the American Red Cross' Hurricane Sandy Relief Fund. - December 12, 2012
Beginning January 1, 2013, BioCat GmbH will be ALPCO's exclusive distributor in Germany. - December 10, 2012
ALPCO to distribute Euro Diagnostica products in North America. - December 07, 2012
A collaboration between ALPCO Diagnostics and the Mayo Clinic has yielded a poster that will be presented at this year’s ASBMR meeting in Minneapolis, MN. - October 04, 2012
ALPCO announces the addition of two FDA Registered ELISAs for the measurement of West Nile Virus. - September 05, 2012
ALPCO Diagnostics announces the launch of an ELISA specific for measuring mouse sclerostin in serum and plasma. - July 10, 2012
Press Releases 1 - 50 of 72 Page: 1 | 2 | Next
Promote Your Business